Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Current Leases: 2019-2025

Historic Current Leases for Prestige Consumer Healthcare (PBH) over the last 7 years, with Sep 2025 value amounting to $6.0 million.

  • Prestige Consumer Healthcare's Current Leases rose 136.25% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 136.25%. This contributed to the annual value of $6.0 million for FY2025, which is 29.82% up from last year.
  • Prestige Consumer Healthcare's Current Leases amounted to $6.0 million in Q3 2025, which was down 0.40% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Current Leases registered a high of $6.9 million during Q1 2023, and its lowest value of $2.6 million during Q3 2024.
  • Its 3-year average for Current Leases is $5.5 million, with a median of $6.0 million in 2025.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Current Leases slumped by 61.97% in 2024, and later surged by 136.25% in 2025.
  • Prestige Consumer Healthcare's Current Leases (Quarterly) stood at $6.3 million in 2021, then grew by 9.33% to $6.9 million in 2022, then declined by 17.61% to $5.7 million in 2023, then increased by 6.51% to $6.0 million in 2024, then surged by 136.25% to $6.0 million in 2025.
  • Its Current Leases was $6.0 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.0 million in Q1 2025.